+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

Palantir plummets 18% after Morgan Stanley downgrades company on questionable valuation following massive run

Dec 3, 2020, 01:00 IST
Business Insider
Arnd Wiegmann/Reuters
  • Palantir plummeted as much as 18% on Wednesday after Morgan Stanley downgraded the company to Under-weight from Equal-weight.
  • Palantir has seen a massive rally since it went public in September, surging as much as 235% based on last Friday's high of $33.50.
  • "With very little change in the fundamental story, the risk/reward paradigm shifts decidedly negative for the shares," Morgan Stanley warned.
  • Visit Business Insider's homepage for more stories.
Advertisement

Palantir declined as much as 18% on Wednesday after the high-flying tech firm was downgraded to "Under-weight" by Morgan Stanley.

An "Under-weight" rating is equivalent to a Sell rating on Wall Street. The downgrade came after Morgan Stanley downgraded Palantir to "Equal-weight" from "Over-weight" last month.

Morgan Stanley set a $17 price target for Palantir, representing potential downside of 34% from Tuesday's close.

The driving factor behind Morgan Stanley's downgrade is a heightened valuation for Palantir with very little change to its fundamental story since the company went public in September.

Shares of Palantir have rallied as much as 235% since its September 30 debut, based off of its all time high of $33.50 reached last Friday.

Advertisement

Read more: Zoom has soared 497% this year. 3 analysts — including one of the most accurate in tech — break down whether you should buy, hold, or sell the stock as a vaccine becomes widely available.

"With very little change in the fundamental story, the risk/reward paradigm shifts decidedly negative for the shares," Morgan Stanley warned.

Morgan Stanley isn't alone in its bearish call on Palantir. Last week, famed short-seller Andrew Left of Citron Research called Palantir's rally unsustainable and called the stock a "casino."

"What a run the past month for all. But as traders looking for short exposure, $PLTR is no longer a stock but a full casino," Citron said.

Citron expects Palantir to tumble to $20 by year-end.

Advertisement

Shares of Palantir are down 33% since last week's high, as of Wednesday afternoon trades.

Read more: HSBC says buy these 31 global stocks that are exposed to the pandemic's biggest tech disruptions and set to become growth engines of the future

Markets Insider

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article